BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The American Association for Homeopathic Products - ECPv6.15.16//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The American Association for Homeopathic Products
X-ORIGINAL-URL:https://theaahp.org
X-WR-CALDESC:Events for The American Association for Homeopathic Products
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260610T120000
DTEND;TZID=America/New_York:20260610T133000
DTSTAMP:20260510T125400
CREATED:20260504T132359Z
LAST-MODIFIED:20260504T135556Z
UID:10000106-1781092800-1781098200@theaahp.org
SUMMARY:FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar
DESCRIPTION:FDA Insights on GMP Violations & AAHP Homeopathic 483 Study Webinar	\n	Hear directly from FDA at AAHP’s upcoming webinar. Learn from the agency about compliance trends and inspection insights relevant to homeopathic drug manufacturers through AAHP’s ongoing Compliance Through Education program. \n	About the Program\nGMP compliance-related issues remain the leading cause of FDA warning letters across the homeopathic industry. This webinar brings together regulatory perspective and industry expertise to help manufacturers better understand what FDA is looking for during inspections.  \nAttendees will gain practical insight into recent compliance actions\, as well as a deeper understanding of common compliance gaps observed during facility inspections so companies can better prepare for their next inspection.  \n	Event Information\n\nVirtual via Zoom\nWednesday\, June 10\, 2026\n12:00 PM – 1:30 ET\nComplimentary to members and non-members  \n\n			\n							Registration Now Open\n					\n	Featured Speakers\n\nFrancis Godwin\, MBA \nDirector\, Office of Manufacturing Quality (OMQ)\, Office of Compliance\, CDER\, FDA Francis Godwin will provide an FDA perspective on recentcompliance actions affecting homeopathic drug products\, drawing on his extensive experience overseeing domestic and international CGMP compliance activities. \n  \n\nEric L. Foxman\, RPh (Ret.) \nSenior Scientist\, HPUS; Former AAHP Secretary and Board Member\nWith more than four decades of experience in the homeopathic industry\, Eric Foxman will present a retrospective review of FDA 483 observations of inspections of homeopathic manufacturing sites\, highlighting key trends and lessons to be learned. \n	What You Will Learn\n\nOverview and examples of inspection compliance. \n\n\nFDA’s hot topics which result in warning letters. \n\n\nWhat inspection observations are made most often across the board. \n\n\nWhat initial areas companies can focus on\, which will make a positive difference in the 483 list of observations. \n\n\nAn overview of the breadth of observations for a second pass at increasing compliance before the next inspection occurs. \n\n	Who Should Attend\nThis seminar is a must-attend for domestic and foreign firms who manufacture\, label\, pack\, or hold homeopathic drug products for sale in the United States.  \n\nQuality Staff \n\n\nLegal & Regulatory Staff \n\n\nProduct Leads \n\n\nProduct R&D Staff \n\n\nCompany Leaders (President/CEO) \n\n\nAnd those similarly responsible at your contract manufacturer \n\n	Please contact Association Manager Hayley Sotolotto via email at info@theaahp.org or by voice message at (413) 515-8133 with questions or concerns. 
URL:https://theaahp.org/event/fda-insights-on-gmp-violations-aahp-homeopathic-483-study-webinar/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://theaahp.org/wp-content/uploads/2022/05/AAHP-Logo-e1677699574756.png
ORGANIZER;CN="The American Association for Homeopathic Products":MAILTO:info@aahp.info
END:VEVENT
END:VCALENDAR